[Vinpotropil in the treatment of dyscirculatory encephalopathy with cognitive impairment without dementia.]

by V V Zakharov
Zh Nevrol Psikhiatr Im S S Korsakova ()


The fixed combination containing 5 mg of vinpocetine and 400 mg of pyracetam (vinpotropil) was prescribed to 349 patients with dyscirculatory encephalopathy, I-II stages in dose one capsule three times a day during 3 months. After this treatment, repeated neuropsychological testing showed significant diminishing of dysexecutive cognitive impairment linked with frontal lobes dysfunction. The cognitive improvement was associated with the regress of subjective neurological symptoms like headache, dizziness, tinnitus, fatigue and insomnia. Vinpotropil was safe and well tolerated in elderly patients with chronic cerebral vascular insufficiency.

Cite this document (BETA)

Readership Statistics

7 Readers on Mendeley
by Discipline
by Academic Status
43% Ph.D. Student
14% Other Professional
14% Librarian
by Country
14% United States


Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in